US Patent 7192931 Treatment of demyelinating diseases
Patent 7192931 was granted and assigned to Neuren Pharmaceuticals on March, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7192931 Treatment of demyelinating diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
